Cargando…
Molecular mechanisms and treatment responses of pulmonary fibrosis in severe COVID-19
BACKGROUND: Coronavirus disease 2019 (COVID-19) patients can develop pulmonary fibrosis (PF), which is associated with impaired outcome. We assessed specific leukocytic transcriptome profiles associated with PF and the influence of early dexamethasone (DEXA) treatment on the clinical course of PF in...
Autores principales: | Kooistra, Emma J., Dahm, Kilian, van Herwaarden, Antonius E., Gerretsen, Jelle, Nuesch Germano, Melanie, Mauer, Karoline, Smeets, Ruben L., van der Velde, Sjef, van den Berg, Maarten J. W., van der Hoeven, Johannes G., Aschenbrenner, Anna C., Schultze, Joachim L., Ulas, Thomas, Kox, Matthijs, Pickkers, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413531/ https://www.ncbi.nlm.nih.gov/pubmed/37559053 http://dx.doi.org/10.1186/s12931-023-02496-1 |
Ejemplares similares
-
The Effects of Cold Exposure Training and a Breathing Exercise on the Inflammatory Response in Humans: A Pilot Study
por: Zwaag, Jelle, et al.
Publicado: (2022) -
Short-term hyperoxia does not exert immunologic effects during experimental murine and
human endotoxemia
por: Kiers, Dorien, et al.
Publicado: (2015) -
Transvenous vagus nerve stimulation does not modulate the innate immune response during experimental human endotoxemia: a randomized controlled study
por: Kox, Matthijs, et al.
Publicado: (2015) -
Short-term repeated HRV-16 exposure results in an attenuated immune response in vivo in humans
por: Koch, Rebecca M., et al.
Publicado: (2018) -
A randomized double‐blind, placebo‐controlled clinical phase IIa trial on safety, immunomodulatory effects and pharmacokinetics of EA‐230 during experimental human endotoxaemia
por: van Groenendael, Roger, et al.
Publicado: (2019)